Cargando…

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Undruggable proteins are a class of proteins that are often characterized by large, complex structures or functions that are difficult to interfere with using conventional drug design strategies. Targeting such undruggable targets has been considered also a great opportunity for treatment of human d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xin, Yu, Tingting, Li, Xiang, Zhang, Nan, Foster, Leonard J., Peng, Cheng, Huang, Wei, He, Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480221/ https://www.ncbi.nlm.nih.gov/pubmed/37669923 http://dx.doi.org/10.1038/s41392-023-01589-z

Ejemplares similares

Drugging the Undruggable: Advances on RAS Targeting in Cancer
por: Molina-Arcas, Miriam, et al.
Publicado: (2021)

Targeted Protein Degradation: An Important Tool for Drug Discovery for “Undruggable” Tumor Transcription Factors
por: Dai, Mengyuan, et al.
Publicado: (2022)

Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019)

Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021)

Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011)

The Future of Medicinal Chemistry, PROTAC, and Undruggable Drug Targets
por: Poso, Antti
Publicado: (2021)

Drugging the undruggables: exploring the ubiquitin system for drug development
por: Huang, Xiaodong, et al.
Publicado: (2016)

Targeting STATs for cancer therapy: “Undruggable” no more
por: Frank, David A.
Publicado: (2012)

Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)

Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets
por: He, Huiqin, et al.
Publicado: (2020)

Targeting bromodomain-containing proteins: research advances of drug discovery
por: Pan, Zhaoping, et al.
Publicado: (2023)

Drugging the “undruggable” DNA-binding domain of STAT3
por: Zhang, Jian-Ting, et al.
Publicado: (2016)

Drugging the undruggable: Ross Cagan interviews Kevan Shokat
por: Cagan, Ross, et al.
Publicado: (2022)

Drugging the Undruggable Trypanosoma brucei Monothiol Glutaredoxin 1
por: Favaro, Annagiulia, et al.
Publicado: (2023)

Targeting the “undruggable” RAS - new strategies - new hope?
por: Mörchen, Britta, et al.
Publicado: (2019)

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome
por: Lee, Kristi Y., et al.
Publicado: (2022)

Commentary: PROTACs make undruggable targets druggable: Challenge and opportunity
por: Lu, Bin, et al.
Publicado: (2021)

Covalent inhibitor targets KRas(G12C): A new paradigm for drugging the undruggable and challenges ahead
por: Li, Hui-yu, et al.
Publicado: (2021)

Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets
por: Moon, Seonghyeon, et al.
Publicado: (2018)

Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
Publicado: (2021)

Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
por: Lam, Kuen Kuen, et al.
Publicado: (2023)

KRAS mutation: from undruggable to druggable in cancer
por: Huang, Lamei, et al.
Publicado: (2021)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes
por: Trkulja, Carolina L., et al.
Publicado: (2021)

Targeting undruggable carbohydrate recognition sites through focused fragment library design
por: Shanina, Elena, et al.
Publicado: (2022)

MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
por: Pang, Jia Meng, et al.
Publicado: (2023)

Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
por: Shillingford, Shanelle R., et al.
Publicado: (2023)

Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
por: Lu, Yuqing, et al.
Publicado: (2023)

Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis
por: de Villiers, Katherine A., et al.
Publicado: (2009)

Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
por: Knott, Maximilian M. L., et al.
Publicado: (2020)

The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
por: Casalino, Laura, et al.
Publicado: (2022)

A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
por: Park, Woo-Jung, et al.
Publicado: (2023)

KRAS G12C mutation: from undruggable target to potentially agnostic biomarker
por: El Osta, Badi
Publicado: (2023)

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”
por: Nagasaka, Misako, et al.
Publicado: (2023)

Design of rigid protein–protein interaction inhibitors enables targeting of undruggable Mcl-1
por: Hargreaves, David, et al.
Publicado: (2023)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

ATNC: Versatile Nanobody Chimeras for Autophagic Degradation of Intracellular Unligandable and Undruggable Proteins
por: He, Huiping, et al.
Publicado: (2023)

Exploration of Dark Chemical Genomics Space via Portal Learning: Applied to Targeting the Undruggable Genome and COVID-19 Anti-Infective Polypharmacology
por: Cai, Tian, et al.
Publicado: (2021)

RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
por: Liu, Xiaoyu, et al.
Publicado: (2023)

The Unpluggable in Pursuit of the Undruggable: Tackling the Dark Matter of the Cancer Therapeutics Universe
por: Epstein, Richard J.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s9qjs7k89iljusjdh645ru5kdq